Unblindable by Design: Comparator Choice and the Camel-Milk Diabetes Literature — A Reanalysis of 14 Randomised Controlled Trials

Background. A meta-analysis of 14 randomised controlled trials (663 participants) reports that camel milk consumption reduces HbA1c by 1.24 percentage points and daily insulin dose by 16.72 U in patients with diabetes. These are large effects for a food. This reanalysis asks whether the trial corpus is capable of supporting them. Methods. Trial-level design characteristics and pooled outcome statistics were extracted from the published meta-analysis (AlKurd et al., Nutrients 2022, CC BY). No primary trial reports were consulted. Blinding completeness, outcome-wise heterogeneity, effect plausibility against indicative values for established glucose-lowering agents, and the sample sizes required to adjudicate the corpus's internal discrepancy were computed. Results. All 14 trials (100%) used "usual care" as comparator, a contrast that cannot be blinded. Adequate sequence generation was reported in 3/14, allocation concealment in 1/14, participant blinding in 2/14, and blinded outcome assessment in 2/14; one trial (7.1%) satisfied all four. Of eight pooled outcomes, six were non-significant, including every mechanistic marker (fasting serum insulin, HOMA-IR, C-peptide, insulin antibodies). The two significant outcomes, HbA1c and insulin dose, are precisely the two that depend on an unblinded investigator, insulin dose being titrated by that investigator. Median I-squared was 94%, with none below 89%. In subgroup analysis, fresh (raw) milk yielded -1.50 points HbA1c (I-squared = 85%) against -0.31 for heat-treated or fermented milk (I-squared = 0.0%): a 4.8-fold difference in which the only internally consistent subgroup in the entire corpus is also the one reporting the smallest effect. Conclusions. The corpus is not weak evidence of an effect; its principal result is not separable from the measurement bias that produced it, and additional participants would not repair this. The parsimonious hypothesis is that the true HbA1c effect is near -0.3 points. The discriminating experiment is a blinded raw-versus-pasteurised comparison, requiring 28 participants if the published subgroup difference is real and 250 under non-inferiority framing. It has not been conducted in 22 years, despite being the least expensive trial in the field and despite an independently documented association between daily raw camel-milk consumption and Brucella seropositivity.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24343163
Primary Topic
Animal Diversity and Health Studies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Unblindable by Design: Comparator Choice and the Camel-Milk Diabetes Literature — A Reanalysis of 14 Randomised Controlled Trials

KARIM ADAMINI EL GHOUILI
Zenodo (CERN European Organization for Nuclear Research)
Animal Diversity and Health Studies
preprint

Unblindable by Design: Comparator Choice and the Camel-Milk Diabetes Literature — A Reanalysis of 14 Randomised Controlled Trials

KARIM ADAMINI EL GHOUILI
preprint en

Abstract

Background. A meta-analysis of 14 randomised controlled trials (663 participants) reports that camel milk consumption reduces HbA1c by 1.24 percentage points and daily insulin dose by 16.72 U in patients with diabetes. These are large effects for a food. This reanalysis asks whether the trial corpus is capable of supporting them. Methods. Trial-level design characteristics and pooled outcome statistics were extracted from the published meta-analysis (AlKurd et al., Nutrients 2022, CC BY). No primary trial reports were consulted. Blinding completeness, outcome-wise heterogeneity, effect plausibility against indicative values for established glucose-lowering agents, and the sample sizes required to adjudicate the corpus's internal discrepancy were computed. Results. All 14 trials (100%) used "usual care" as comparator, a contrast that cannot be blinded. Adequate sequence generation was reported in 3/14, allocation concealment in 1/14, participant blinding in 2/14, and blinded outcome assessment in 2/14; one trial (7.1%) satisfied all four. Of eight pooled outcomes, six were non-significant, including every mechanistic marker (fasting serum insulin, HOMA-IR, C-peptide, insulin antibodies). The two significant outcomes, HbA1c and insulin dose, are precisely the two that depend on an unblinded investigator, insulin dose being titrated by that investigator. Median I-squared was 94%, with none below 89%. In subgroup analysis, fresh (raw) milk yielded -1.50 points HbA1c (I-squared = 85%) against -0.31 for heat-treated or fermented milk (I-squared = 0.0%): a 4.8-fold difference in which the only internally consistent subgroup in the entire corpus is also the one reporting the smallest effect. Conclusions. The corpus is not weak evidence of an effect; its principal result is not separable from the measurement bias that produced it, and additional participants would not repair this. The parsimonious hypothesis is that the true HbA1c effect is near -0.3 points. The discriminating experiment is a blinded raw-versus-pasteurised comparison, requiring 28 participants if the published subgroup difference is real and 250 under non-inferiority framing. It has not been conducted in 22 years, despite being the least expensive trial in the field and despite an independently documented association between daily raw camel-milk consumption and Brucella seropositivity.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Animal Diversity and Health Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon